This inventor holds 4 USPTO granted patents, plus 1 CIPO patent and 3 EPO patents. Top assignees: Oxford University Innovation Ltd, Innovation Ulster Limited, University of Ulster. Active years: 2020-2026.
Location History:
- Oxfordshire, GB (2021)
- Oxford, GB (2020 - 2022)
Company Filing History:


Years Active: 2020-2026
Title: Eleanor Stride: Innovator in Sonodynamic Therapy
Introduction
Eleanor Stride is a prominent inventor based in Oxford, GB, known for her significant contributions to the field of sonodynamic therapy. With a total of three patents to her name, she has made remarkable strides in developing innovative methods for cancer treatment.
Latest Patents
One of her latest patents is titled "Microbubble-chemotherapeutic agent complex for sonodynamic therapy." This invention relates to methods of sonodynamic therapy that involve the co-administration of a microbubble-chemotherapeutic agent complex alongside a microbubble-sonosensitiser complex. The pharmaceutical compositions derived from this invention are particularly useful in treating cancers, such as pancreatic cancer. Another notable patent is the "Method and apparatus for generating bubbles." This method involves generating bubbles of a first fluid in a second fluid by flowing the second fluid through a microfluidic channel and injecting the first fluid to form bubbles, which are then divided using ultrasound.
Career Highlights
Eleanor has worked with esteemed organizations such as Oxford University Innovation Limited and the University of Ulster. Her work has significantly impacted the development of therapeutic techniques that leverage ultrasound technology for medical applications.
Collaborations
Eleanor has collaborated with notable individuals in her field, including John Francis Callan and Anthony Patrick McHale. These partnerships have further enhanced her research and innovation efforts.
Conclusion
Eleanor Stride's contributions to sonodynamic therapy and her innovative patents highlight her role as a leading inventor in the medical field. Her work continues to pave the way for advancements in cancer treatment methodologies.